Total Payments
$14,541
2024 Payments
$1,583
Companies
40
Transactions
841
Medicare Patients
16,889
Medicare Billing
$2.6M
Payment Breakdown by Category
Food & Beverage$11,712 (80.5%)
Travel$2,785 (19.2%)
Education$43.97 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,712 | 826 | 80.5% |
| Travel and Lodging | $2,785 | 12 | 19.2% |
| Education | $43.97 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $3,305 | 191 | $0 (2024) |
| Abbott Laboratories | $2,564 | 113 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,638 | 146 | $0 (2024) |
| The Spectranetics Corporation | $1,333 | 8 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $1,295 | 98 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $595.87 | 71 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $565.86 | 29 | $0 (2024) |
| Amgen Inc. | $466.10 | 33 | $0 (2023) |
| PFIZER INC. | $355.66 | 25 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $320.02 | 15 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,583 | 168 | Boston Scientific Corporation ($474.41) |
| 2023 | $1,555 | 98 | Novartis Pharmaceuticals Corporation ($383.19) |
| 2022 | $1,190 | 90 | Boston Scientific Corporation ($251.95) |
| 2021 | $1,467 | 120 | Janssen Pharmaceuticals, Inc ($322.27) |
| 2020 | $1,015 | 71 | Janssen Pharmaceuticals, Inc ($181.33) |
| 2019 | $1,515 | 104 | Abbott Laboratories ($734.83) |
| 2018 | $1,907 | 107 | Abbott Laboratories ($891.58) |
| 2017 | $4,308 | 83 | BOSTON SCIENTIFIC CORPORATION ($1,747) |
All Payment Transactions
841 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $8.96 | General |
| Category: Cardiovascular | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $0.98 | General |
| Category: Cardiovascular | ||||||
| 12/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $1.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $1.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $1.53 | General |
| Category: AVVIGO_IC | ||||||
| 11/23/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $0.74 | General |
| Category: AVVIGO_IC | ||||||
| 11/20/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: AVVIGO_IC | ||||||
| 11/14/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $7.73 | General |
| Category: AVVIGO_IC | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $11.55 | General |
| Category: Cardiovascular | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $12.48 | General |
| Category: Cardiovascular | ||||||
| 11/12/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $0.87 | General |
| Category: AVVIGO_IC | ||||||
| 11/11/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: AVVIGO_IC | ||||||
| 11/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.64 | General |
| Category: Obesity | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: AVVIGO_IC | ||||||
| 11/05/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $0.91 | General |
| Category: AVVIGO_IC | ||||||
| 11/01/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $0.98 | General |
| Category: AVVIGO_IC | ||||||
| 10/30/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $5.14 | General |
| Category: AVVIGO_IC | ||||||
| 10/30/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $0.87 | General |
| Category: AVVIGO_IC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 4,399 | 6,100 | $2.0M | $806,871 |
| 2022 | 33 | 4,440 | 6,012 | $1.5M | $639,282 |
| 2021 | 34 | 4,342 | 5,944 | $1.6M | $648,302 |
| 2020 | 35 | 3,708 | 5,112 | $1.3M | $530,380 |
Total Patients
16,889
Total Services
23,168
Medicare Billing
$2.6M
Procedure Codes
143
All Medicare Procedures & Services
143 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 140 | 140 | $392,000 | $194,186 | 49.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 811 | 1,615 | $291,820 | $156,763 | 53.7% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 140 | 140 | $224,000 | $87,198 | 38.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 339 | 348 | $191,070 | $57,121 | 29.9% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 61 | 61 | $97,600 | $45,554 | 46.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 238 | 242 | $106,480 | $39,907 | 37.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 89 | 89 | $89,000 | $34,567 | 38.8% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 190 | 190 | $87,400 | $29,892 | 34.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 172 | 688 | $55,040 | $28,165 | 51.2% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Office | 2023 | 140 | 140 | $67,900 | $22,765 | 33.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 236 | 237 | $71,100 | $13,761 | 19.4% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 24 | 27 | $58,050 | $12,703 | 21.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 95 | 95 | $28,930 | $11,926 | 41.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 760 | 1,019 | $45,855 | $11,670 | 25.4% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 45 | 47 | $34,450 | $8,964 | 26.0% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 32 | 32 | $17,600 | $6,818 | 38.7% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 26 | 27 | $20,250 | $6,197 | 30.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 71 | 86 | $10,320 | $5,599 | 54.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 37 | 37 | $13,320 | $5,406 | 40.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 42 | 43 | $10,750 | $4,714 | 43.9% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 69 | 69 | $18,375 | $4,373 | 23.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 30 | $7,550 | $4,274 | 56.6% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2023 | 339 | 348 | $13,920 | $3,757 | 27.0% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 20 | 22 | $9,300 | $2,509 | 27.0% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Facility | 2023 | 23 | 23 | $5,750 | $2,053 | 35.7% |
About Dr. Rayson Yang, M.D
Dr. Rayson Yang, M.D is a Cardiovascular Disease healthcare provider based in Toms River, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841301637.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rayson Yang, M.D has received a total of $14,541 in payments from pharmaceutical and medical device companies, with $1,583 received in 2024. These payments were reported across 841 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($11,712).
As a Medicare-enrolled provider, Yang has provided services to 16,889 Medicare beneficiaries, totaling 23,168 services with total Medicare billing of $2.6M. Data is available for 4 years (2020–2023), covering 143 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Toms River, NJ
- Active Since 08/31/2006
- Last Updated 08/22/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1841301637
Products in Payments
- XARELTO (Drug) $1,295
- ELCAELCA X-80 (Device) $1,292
- ENTRESTO (Drug) $1,237
- GENERAL - ATHERECTOMY (Device) $914.78
- ELIQUIS (Drug) $728.87
- Asahi Fielder coronary guide wire (Device) $692.81
- GENERAL - VASCULAR ACCESS (Device) $654.12
- AVVIGO Guidance System (Device) $567.31
- Xience Sierra Coronary Stent System (Device) $543.00
- LEQVIO (Drug) $401.71
- BRILINTA (Drug) $355.48
- LifeVest (Device) $320.02
- COMET (Device) $295.86
- Confirm Rx (Device) $293.15
- Repatha (Biological) $247.88
- Xience Alpine cornary stent system (Device) $241.98
- WATCHMAN (Device) $236.33
- Corlanor (Drug) $218.22
- VERQUVO (Drug) $204.69
- FARXIGA (Drug) $196.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Toms River
Hani Douedi, Md, MD
Cardiovascular Disease — Payments: $104,307
Cardiovascular Disease $104,307
Dr. Joseph Guarino, M.d, M.D
Cardiovascular Disease — Payments: $20,671
Cardiovascular Disease $20,671
Dr. Kock-Yen Tsang, M.d, M.D
Cardiovascular Disease — Payments: $15,786
Cardiovascular Disease $15,786
John Merlino, Do, DO
Cardiovascular Disease — Payments: $15,000
Cardiovascular Disease $15,000
Dr. Richard Chang, Do, DO
Cardiovascular Disease — Payments: $10,226
Cardiovascular Disease $10,226
Dr. Victor Bacani, M.d, M.D
Cardiovascular Disease — Payments: $9,419
Cardiovascular Disease $9,419